Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06701604 · ClinicalTrials.gov registry record · NA
Changes in Amino Acid Absorption After Adding a Probiotic to an Acute Protein Feeding
A NA study, sponsored by The Archer-Daniels-Midland Company.
- Not yet
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT06701604: Clinical Trial NA study, sponsored by The Archer-Daniels-Midland Company.
NCT06701604 is a NA study that has not yet begun recruiting, run by The Archer-Daniels-Midland Company. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06701604, a NA study, has not yet begun recruiting, sponsored by The Archer-Daniels-Midland Company.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the rate and concentration of amino acid absorption after a three-week pattern of milk protein supplementation with and without the addition of a single strain probiotic.
Primary Outcome
To determine if the addition of a probiotic to milk protein ingestion changes the rate (in minutes) to which amino acids are absorbed into our bloodstream.
Interventions
- DIETARY_SUPPLEMENT Single Strain Probiotic + Milk Protein
- DIETARY_SUPPLEMENT Placebo + Milk Protein
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-12-02 |
| Est. Completion | 2026-01-15 |
| Phase | NA |
What is known before NCT06701604 opens enrollment
NCT06701604 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Single Strain Probiotic + Milk Protein is the first listed.
NCT06701604 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06701604 about?
NCT06701604 is a clinical study titled "Changes in Amino Acid Absorption After Adding a Probiotic to an Acute Protein Feeding". The purpose of this study is to examine the rate and concentration of amino acid absorption after a three-week pattern of milk protein supplementation with and without the addition of a single strain probiotic.
What is the current status of trial NCT06701604?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-12-02. Estimated completion is 2026-01-15.
What interventions are being tested in trial NCT06701604?
The interventions under investigation include: Single Strain Probiotic + Milk Protein (DIETARY_SUPPLEMENT), Placebo + Milk Protein (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06701604?
This trial is sponsored by The Archer-Daniels-Midland Company, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06701604's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI